Revenue - Revenue for the nine months ended September 30, 2021 was approximately $400,000, compared to $62,000 for the same period in 2020, representing a significant increase [65]. Operating Expenses - Operating expenses for the three months ended September 30, 2021 totaled approximately $4.1 million, an increase from $3.6 million in the same period of 2020, reflecting a rise of approximately 14% [67]. - Research and development expenses for the three months ended September 30, 2021 were approximately $2.2 million, up from $2.0 million in 2020, marking an increase of approximately 9% [68]. - General and administrative expenses for the three months ended September 30, 2021 were approximately $1.6 million, an increase of approximately $315,000 or 24% compared to the same period in 2020 [69]. - Selling and marketing expenses for the three months ended September 30, 2021 were approximately $267,000, representing an increase of approximately 28% from $208,000 in 2020 [70]. Cash and Working Capital - As of September 30, 2021, the company had cash and cash equivalents of approximately $31.8 million and working capital of approximately $29.3 million [76]. Cash Flow - The net cash used in operating activities for the nine months ended September 30, 2021 was approximately $9.4 million, primarily due to a net loss of approximately $11.5 million [74]. Future Outlook - The company anticipates that its cost of revenue will vary substantially depending on the mix of integration license and integration engineering services provided [65]. - Future capital requirements will depend on the successful commercialization of MST technology and the need for collaborations or acquisitions to enhance offerings [77]. Accounting and Controls - The company has not entered into any off-balance sheet arrangements or issued guarantees to third parties [78]. - No changes to critical accounting policies from the Annual Report on Form 10-K for the year ended December 31, 2020 [81]. - Management concluded that disclosure controls and procedures were effective as of September 30, 2021 [81]. - No changes to internal controls over financial reporting during the three-month period ended September 30, 2021 [82].
Atomera(ATOM) - 2021 Q3 - Quarterly Report